Determinants of relapse periodicity in Plasmodium vivax malaria
A long neglected world malaria map: Plasmodium vivax endemicity in 2010The potential elimination of Plasmodium vivax malaria by relapse treatment: insights from a transmission model and surveillance data from NW IndiaPrimaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquineThe role of early detection and treatment in malaria eliminationTafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to dateTying malaria and microRNAs: from the biology to future diagnostic perspectivesMalaria's contribution to World War One - the unexpected adversaryPrimaquine radical cure of Plasmodium vivax: a critical review of the literatureGenomic analysis of local variation and recent evolution in Plasmodium vivax.1H NMR metabonomics indicates continued metabolic changes and sexual dimorphism post-parasite clearance in self-limiting murine malaria modelMalaria modeling: In vitro stem cells vs in vivo modelsTherapeutic efficacy of alternative primaquine regimens to standard treatment in preventing relapses by Plasmodium vivax: A systematic review and meta-analysisEpidemiology of Plasmodium vivax Malaria in PeruImplications of Plasmodium vivax Biology for Control, Elimination, and ResearchMalaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational studySuppressive chemoprophylaxis invites avoidable risk of serious illness caused by Plasmodium vivax malariaEfficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studiesA high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings.Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivoStrategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical modelA new Plasmodium vivax reference sequence with improved assembly of the subtelomeres reveals an abundance of pir genesClinical, geographical, and temporal risk factors associated with presentation and outcome of vivax malaria imported into the United Kingdom over 27 years: observational studyGlobal Epidemiology of Plasmodium vivaxMalaria in the Americas: trends from 1959 to 2011Long-lasting transition toward sustainable elimination of desert malaria under irrigation developmentThe Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trialsHousehold level spatio-temporal analysis of Plasmodium falciparum and Plasmodium vivax malaria in EthiopiaMulti-strain infections and 'relapse' of Leucocytozoon sabrazesi gametocytes in domestic chickens in southern China.Clinical profile of Plasmodium falciparum and Plasmodium vivax infections in low and unstable malaria transmission settings of Colombia.Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models.The burden of Plasmodium vivax relapses in an Amerindian village in French GuianaChloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India.Geographical variation in Plasmodium vivax relapseComparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trialThe role of submicroscopic parasitemia in malaria transmission: what is the evidence?Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodesMalaria caused by Plasmodium vivax: recurrent, difficult to treat, disabling, and threatening to life--the infectious bite preempts these hazardsBurden and impact of Plasmodium vivax in pregnancy: A multi-centre prospective observational study.Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru.An outbreak of locally acquired Plasmodium vivax malaria among migrant workers in Oman.
P2860
Q21144495-4F191AB5-88E1-4F92-B8F9-4236FCE22F7DQ21562247-390060BE-6E8A-4B00-8BD2-D64D2DB353EEQ24202900-0F872D62-3948-4B63-871C-F4AE7EEBFD8DQ26740068-9F8E3A5D-1282-4A28-87E0-29C68A77E426Q26741307-E6B1F11E-EE1A-41E1-ADE1-48BACAD2B9A7Q26765405-CE76BAD3-88CB-4412-AEDE-EFD4986107F8Q27011258-124167A2-7DFD-4C3D-81BB-805F75F1F13EQ27027939-33C4F402-4738-485F-876C-FB0B5FC42E7DQ27149930-E8CA1E6E-DAA7-42FE-915A-36F2D33E4D53Q27313337-A67227CF-4EBB-4FE6-8923-F9DA69FBAA53Q28071293-D881B0AE-463B-44B8-A68A-160812E7F6CDQ28076056-5AA0124E-85EE-4A87-861A-92AB0E875D05Q28355360-1B162ABE-AC60-42C8-8FA1-A895F3B7CCC8Q28355362-B2DB7A61-1942-4BFF-860E-61AC4E84BE79Q28487636-1E22BF1E-3420-40D8-8BE2-0C7DAAF8012CQ28488306-C5C9130C-A344-4EC4-94AB-7FD858C38579Q28535686-D4C37107-9540-403B-9B7F-076851EDE7EDQ28539392-54D8CE60-BC03-4FBA-9F42-8DBF5AF3FCB3Q28544459-80341E59-1C84-4543-BBEF-4F8A4A1A96F5Q28550515-C158C710-F559-407B-8F3C-6D55EADC1B1EQ28585693-EC3B8DD8-7294-4AFE-90F1-770F192B62B0Q28648383-D667E710-A602-4EB2-A9F3-7E92A86262B5Q30249044-4183EBEF-83CC-41D0-BE90-9ECB028E4FB5Q30389340-861BE3AC-BC89-47F3-AACE-D5E14C0EC6E8Q30393089-C1204F7E-94FB-4F6F-A7AD-C81E6E95A476Q30491343-AF993BAD-3D3E-41BE-BF2D-E7B5674716A3Q30846328-8A128D4B-7913-40B8-B0D8-FC8990191566Q31158558-DA490978-3640-4ACA-955F-3E5AFC814B62Q33422134-02AD8551-F3A9-4FAE-ACBD-ABB4D88F15C8Q33572458-5FD720E8-CB2E-47DB-B981-686D051E24D5Q33590003-5CAEA8E1-8C79-461D-B4CF-71C3F68C7368Q33612286-10E84094-F029-490B-9208-69F7F640F911Q33613545-08E11B24-3222-4F67-BE91-6BC61110CE4DQ33693625-74CB0DED-6763-46AA-91CB-2F4C5F6A2AFDQ33724777-3F78FD45-B66E-429B-A748-7C47DC8A7547Q33743556-550AE067-7A57-462A-8A1D-0434B1258729Q33815207-EA66F2A8-CCD0-440A-AF5A-D896E83E51B2Q33825631-C73CA18E-D50D-4EE2-BFED-23588BB7E35EQ33841091-E5850768-9499-4E10-A761-C53563EBB6ABQ33893028-19DADDDE-050A-4EA8-ABF0-E9C10487001B
P2860
Determinants of relapse periodicity in Plasmodium vivax malaria
description
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
Scientific Article about Malaria from Malaria Journal
@en
article scientifique (publié 2011)
@fr
articolo scientifico (pubblicato il 2011)
@it
artigo científico (publicado na 2011)
@pt
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
artículu científicu espublizáu en 2011
@ast
name
Determinants of relapse periodicity in Plasmodium vivax malaria
@ast
Determinants of relapse periodicity in Plasmodium vivax malaria
@en
Determinants of relapse periodicity in Plasmodium vivax malaria
@en-gb
Determinants of relapse periodicity in Plasmodium vivax malaria
@nl
type
label
Determinants of relapse periodicity in Plasmodium vivax malaria
@ast
Determinants of relapse periodicity in Plasmodium vivax malaria
@en
Determinants of relapse periodicity in Plasmodium vivax malaria
@en-gb
Determinants of relapse periodicity in Plasmodium vivax malaria
@nl
prefLabel
Determinants of relapse periodicity in Plasmodium vivax malaria
@ast
Determinants of relapse periodicity in Plasmodium vivax malaria
@en
Determinants of relapse periodicity in Plasmodium vivax malaria
@en-gb
Determinants of relapse periodicity in Plasmodium vivax malaria
@nl
P2860
P921
P3181
P356
P1433
P1476
Determinants of relapse periodicity in Plasmodium vivax malaria
@en
P2860
P2888
P3181
P356
10.1186/1475-2875-10-297
P407
P5008
P577
2011-10-11T00:00:00Z
P5875
P6179
1026264436